Page last updated: 2024-12-06

light green sf

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Light green SF: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

acid green 5 : An organic sodium salt having 3-[(ethyl{4-[(4-{ethyl[(3-sulfonatophenyl)methyl]amino}phenyl)(4-sulfonatophenyl)methylidene]cyclohexa-2,5-dien-1-ylidene}azaniumyl)methyl]benzene-1-sulfonate as the counterion. It is the standard dye in North American for staining collagen and is also used extensively in plant histology. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID21223
CHEBI ID87065
SCHEMBL ID333260
MeSH IDM0066615

Synonyms (107)

Synonym
disodium 3-[(ethyl{(1z,4z)-4-[(4-{ethyl[(3-sulfonatophenyl)methyl]amino}phenyl)(4-sulfonatophenyl)methylidene]cyclohexa-2,5-dien-1-ylidene}ammonio)methyl]benzenesulfonate
fd & c green no. 2
nsc 9619
fd&c green no. 2
zelen svetla sf [czech]
benzenemethanaminium, n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(4-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, inner salt, disodium salt
fd and c green no. 4
ccris 889
ammonium, ethyl(4-(p-(ethyl(m-sulfobenzyl)amino)-alpha-(p-sulfophenyl)benzylidene)-2,5-cyclohexadien-1-ylidene)(m-sulfobenzyl)-, hydroxide, inner salt, disodium salt
lichtgruen [german]
benzenemethanaminium, n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(4-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, hydroxide, inner salt, disodium salt
benzenemethanaminium, n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(4-sulfophenyl)methy lene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, hydroxide, inner salt, disodium salt
fd&c green no. 2 - aluminum lake
zelen kysela f [czech]
c.i. 670
einecs 225-906-5
light green fcf yellowish
zelen kysela 5 [czech]
zelen potravinarska 2 [czech]
dihydrogen (ethyl)(4-(p-(ethyl(m-sulphonatobenzyl)amino)-p'-sulphonatobenzhydrylene)cyclohexa-2,5-dien-1-ylidene)(m-sulphonatobenzyl)ammonium, disodium salt
d&c green no. 2
my/68
lissamine green sf
sulfo green j
light green 2gn
light green lake
c.i. food green 2
light green sfa
leather green sf
light sf yellowish (biological stain)
light green g
acid green 5
lissamine lake green sf
light green sfd
fast acid green n
c.i. acid green 5
acilan green sfg
light green s
lichtgruen
light green sf
a.f. green no. 2
acidal light green sf
fenazo green 7g
food green 2
a f green no.2
sumitomo light green sf yellowish
pencil green sf
merantine green sf
fd and c green no. 2-aluminum lake
light green fs
d and c green no. 4
amacid green g
acid brilliant green sf
green no. 203
light green yellowish
nsc-9619
light green cf
5141-20-8
light green sf yellowish
c.i. acid green 5, disodium salt
acid green gg
L0054
L0141
guinea green 2g
zelen svetla sf
benzenemethanaminium, n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(4-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, inner salt, sodium salt (1:2)
hsdb 8009
3f7bha64z0 ,
unii-3f7bha64z0
zelen kysela 5
zelen kysela f
zelen potravinarska 2
FT-0627852
AKOS015902760
AKOS025310847
light green sf yellowish [mi]
midori205
benzenemethanaminium, n-ethyl-n-((1z,4z)-4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(4-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, inner salt, disodium salt
green no. 205
midori205 [inci]
benzenemethanaminium, n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(4-sulfophenyl)methy lene)- 2,5-cyclohexadien-1-ylidene)-3-sulfo-, hydroxide, inner salt, disodium salt
acid brilliant green 5
fd&c green no. 2 (delisted)
light green sf [iarc]
ci 42095
disodium 3-((ethyl((1z,4z)-4-((4-(ethyl(3-sulphonatobenzyl)amino)phenyl)(4-sulphonatophenyl)methylene)cyclohexa-2,5-dien-1-ylidene)ammonio)methyl)benzenesulphonate
disodium 3-((ethyl((1z,4z)-4-((4-(ethyl(3-sulfonatobenzyl)amino)phenyl)(4-sulfonatophenyl)methylene)cyclohexa-2,5-dien-1-ylidene)ammonio)methyl)benzenesulfonate
SCHEMBL333260
CHEBI:87065 ,
disodium 3-[(ethyl{4-[(4-{ethyl[(3-sulfonatophenyl)methyl]amino}phenyl)(4-sulfonatophenyl)methylidene]cyclohexa-2,5-dien-1-ylidene}azaniumyl)methyl]benzene-1-sulfonate
mfcd00012121
DTXSID8020672 ,
DB11183
sodium 3-(((e)-ethyl((e)-4-((4-(ethyl(3-sulfonatobenzyl)amino)phenyl)(4-sulfonatophenyl)methylene)cyclohexa-2,5-dienylidene)ammonio)methyl)benzenesulfonate
Q6546012
disodium;3-[[n-ethyl-4-[[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]-(4-sulfonatophenyl)methyl]anilino]methyl]benzenesulfonate
sodium 3-((ethyl((1e,4e)-4-((4-(ethyl(3-sulfonatobenzyl)amino)phenyl)(4-sulfonatophenyl)methylene)cyclohexa-2,5-dien-1-ylidene)ammonio)methyl)benzenesulfonate
sodium 3-((-ethyl(-4-((4-(ethyl(3-sulfonatobenzyl)amino)phenyl)(4-sulfonatophenyl)methylene)cyclohexa-2,5-dien-1-ylidene)ammonio)methyl)benzenesulfonate
D91235
sodium3-((-ethyl(-4-((4-(ethyl(3-sulfonatobenzyl)amino)phenyl)(4-sulfonatophenyl)methylene)cyclohexa-2,5-dien-1-ylidene)ammonio)methyl)benzenesulfonate
AS-83738
n-ethyl-n-(4-((3-sulfophenyl)methyl)amino)-phenyl)-(4-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfobenzenemethanaminium hydroxide inner salt, disodium salt
light green sf (iarc)
disodium 3-((ethyl(4-((4-(ethyl((3-sulfonatophenyl)methyl)amino)phenyl)(4-sulfonatophenyl)methylidene)cyclohexa-2,5-dien-1-ylidene)azaniumyl)methyl)benzene-1-sulfonate
d&c green no. 4
greenglo
dtxcid60672

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Adverse effects on anterior and posterior segments were evaluated by slit lamp biomicroscopy and ophthalmoscopy."( Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study.
Eibl, K; Freyer, W; Haritoglou, C; Kampik, A; Mankowska, A; May, CA; Rejdak, R; Schuettauf, F; Thaler, S; Zrenner, E, 2006
)
0.33
"BPB or LGSF produced no significantly detectable toxic effects on the retina in vivo."( Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study.
Eibl, K; Freyer, W; Haritoglou, C; Kampik, A; Mankowska, A; May, CA; Rejdak, R; Schuettauf, F; Thaler, S; Zrenner, E, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
histological dyeA dye used in microscopic or electron microscopic examination of cells and tissues to give contrast and to highlight particular features of interest, such as nuclei and cytoplasm.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic sodium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (45.45)18.7374
1990's1 (9.09)18.2507
2000's2 (18.18)29.6817
2010's1 (9.09)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.84 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index45.59 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]